European Ventral Hernia Biologics Market to Triple Over the Next Five Years

TORONTO, Nov. 22, 2010 /PRNewswire/ -- According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, the European market for ventral hernia biologic mesh, comprising xenograft sales only, will triple in size over the next five years.

Through 2015, strong growth in the biologic mesh market will accompany rising awareness among surgeons of the devices' effectiveness for complicated hernia repairs. Leading competitors—including Cook, Covidien, C. R. Bard, and LifeCell—have placed a greater focus on promoting the benefits of biologic mesh for ventral hernia repairs, which will increase adoption of the devices in the coming years. In particular, LifeCell has capitalized on interest in xenograft meshes, and has experienced remarkable growth over 2009. In addition, biologic mesh sales will be fueled by the adoption of tension-free repairs by newly practicing surgeons satisfied with the benefits associated with ventral hernia meshes. There are, however, larger variances in the uptake of biologic meshes in the four major European countries.

"The UK is the largest market for sales of biologic meshes due to favorable government reimbursement and strong surgeon acceptance of the product," says Shriram Venkataramana, Analyst at MRG. "Favorable responses to these products from key opinion leaders in Italy has speeded this adoption, and the xenograft mesh market is set to expand at a rapid rate in Italy and Germany. In France, however, sales of biologic meshes have been less prominent."

MRG's European Markets for Soft Tissue Repair Devices 2011 report provides critical insight into trends that will fuel and limit market growth for soft tissue repair devices in Europe, with coverage of France, Germany, Italy, and the UK. The report includes a breakdown of unit volumes, average selling prices, and market values for devices used in vaginal slings, ventral hernia repair, inguinal hernia repair, pelvic floor reconstruction, and dural repair in addition to an extensive breakdown of procedure volumes.

About Millennium Research Group

Millennium Research Group (www.MRG.net), a Decision Resources, Inc. company (www.DecisionResourcesInc.com), is the global authority on medical technology market intelligence and the leading provider of strategic information to the healthcare sector. The company provides specialized industry expertise through multiclient market research, ongoing Marketrack™ projects, customer behavior tracking, facility-level procedure forecasting, and customized solutions.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information, and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand, or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE Millennium Research Group

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

440k+
Newsrooms &
Influencers

9k+
Digital Media
Outlets

270k+
Journalists
Opted In

GET STARTED